What is changing in the rules, what it means for your product, your municipality or your project, and who here handles it. In English and Portuguese.
Our monitoring reports record the changes to cosmetics rules in a given period, and we publish one each month. Each one is a dated publication: it reflects the rules on the date it was published and is not updated afterwards. For what applies today, read the latest briefings or ask us.
Ingredients: SILVER
Date of publication: 27/03/2024
On March 27 2024, the Scientific Committee on Consumer Safety (SCCS) published the Preliminary Opinion on the safety of Silver in cosmetic products.
Ingredients: EHMC
Date of publication: 28/02/2024
The European Commission has requested the Scientific Committee on Consumer Safety (SCCS) to assess the safety of Ethylhexyl Methoxycinnamate (EHMC). The SCCS approved this mandate on February 28 2024, and the Committee has now nine months to deliver its opinion.
Ingredients: Dimethyltolyamine, Trimethylbenzoyl Diphenylphosphine Oxide - TPO
Date of publication: 05/01/2024
On 5 January 2024, the EU amended the CLP Regulation for harmonized classification and labeling of substances.
Ingredients: Methyl Salicylate
Date of publication: 08/03/2024
On 8 March 2024, the UK SAG-CS published its Final Opinion on Methyl Salicylate as used in various cosmetic product types and age groups.
Topic: New obligations in France under AGEC Law
Date of publication: 12/10/2023
On 12 October 2023, France’s Minister of Ecological Transition and Territorial Cohesion published 3 Decrees relating to substances with endocrine disrupting properties.
Topic: REACH Authorization List - Consultation on the 12th Draft Recommendation
Date of publication: 07/02/2024
On February 7, 2024, the European Chemicals Agency (ECHA) and the European Commission (EC) initiated a simultaneous three-month consultation regarding ECHA's 12th draft recommendation for the REACH Authorization List (Annex XIV), which recommends the inclusion of 5 substances to the list.
Topic: Amendment to EU Cosmetics Regulation
Date of publication: 14/03/2024
On March 14, 2024, the European Commission published Regulation (EU) 2024/858 amending Cosmetics Regulation (EC) No 1223/2009, with updated Annexes II and III regarding the use of certain nanomaterials in cosmetic products.
Ingredients: BENZOPHENONE-4
Date of publication: 27/03/2024
On March 27, 2024, the Scientific Committee on Consumer Safety (SCCS) published its Final Opinion on the use of UV-filter Benzophenone-4 in cosmetic products.
Ingredients: ACETYLATED VEVITER OIL
Date of publication: 28/02/2024
On February 28 2024, the Scientific Committee on Consumer Safety (SCCS) published a preliminary Opinion on the inhalation toxicity of the fragrance ingredient Acetylated Vetiver Oil (AVO, CAS No 84082-84-8, EC No 282-031-1) in sprayable cosmetic products. The deadline for comments is set to May 3, 2024.
Ingredients: HYDROXYPROPYL P-PHENYLENEDIAMINE
Date of publication: 28/02/2024
On February 28, 2024, the Scientific Committee on Consumer Safety (SCCS) published its Final Opinion on the use of the hair dye Hydroxypropyl p-phenylenediamine and its dihydrochloride salt in cosmetic products.
Ingredient: CYCLAMEN ALDEHYDE
Date of publication: 8 June 2026
The Scientific Committee on Consumer Safety (SCCS) has accepted a mandate to assess the safety of Cyclamen Aldehyde, following potential classification as a reproductive toxicant under the CLP Regulation.
Topic: OMNIBUS ACT IX - COSMETICS REGULATION
Date of publication: 28 July 2026
The European Commission notified the WTO about the draft Omnibus Act IX, proposing amendments to Annexes II, III, and V of the EU Cosmetics Regulation.
Topic: NEW RESTRICTIONS ON COSMETIC INGREDIENTS
Date of publication: 13 January 2026
The European Commission published Commission Regulation (EU) 2026/78, which brings new restrictions on several cosmetic ingredients that were classified as Carcinogenic, Mutagenic or Toxic for Reproduction (CMR).
Ingredient: TALC
Date of publication: January 2026
The United Kingdom (UK) Health and Safety Executive (HSE) has published a technical report concluding that Talc does not warrant carcinogenicity classification, diverging from ECHA's Risk Assessment Committee (RAC) opinion supporting Category 1B classification.
Four EUDAMED modules have been mandatory since 28 May 2026. Devices already on the market have until 27 November 2026. Who registers what, and what changed in Portugal.
From 25 February 2027, notified bodies under the MDR and IVDR must quote on defined information, keep to maximum timelines and publish their performance. What it changes for manufacturers.
Whether software is a medical device depends on what you say it is for, not on the code. The qualification test under the MDR and IVDR, updated for 2025 guidance.
Clinical data from an equivalent device can support your clinical evaluation, but the MDR sets a higher bar than the Directives did. The three characteristics, data access, and documentation.
One email when an area publishes, in the language you choose. Nothing else.
